The Biology of CD45 and its Use as a Therapeutic Target

References

• Poppema, S., Lai, R., Visser, L. and Yan, X.J. (1996) "CD45 (leucocyte common antigen) expression in T and B lymphocyte subsets", Leukemia & Lymphoma, 20(3–4), 217–222.
   Google Scholar
• Thomas, M.L. (1994) "The regulation of B- and T-lymphocyte activation by the transmembrane protein tyrosine phosphatase CD45", Current Opinion in Cell Biology, 6(2), 247–252.
   PubMed Web of Science ®Google Scholar
• Trowbridge, I.S. and Thomas, M.L. (1994) "CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development", Annual Review of Immunology, 12, 85 —116.
   Google Scholar
• Woodford-Thomas, T. and Thomas, M.L. (1993) "The leukocyte common antigen, CD45 and other protein tyrosine phosphatases in hemopoietic cells", Seminars in Cell Biology, 4(6), 409–418.
   PubMedGoogle Scholar
• Clark, E.A. and Ledbetter, J.A. (1989) "Leukocyte cell surface enzymology: CD45 (LCA, T200) is a protein tyrosine phosphatase", Immunology Today, 10(7), 225–228.
   PubMedGoogle Scholar
• Hermiston, M.L., Xu, Z. and Weiss, A. (2003) "CD45: A critical regulator of signaling thresholds in immune cells", Annual Review of Immunology, 21, 107–137.
   PubMed Web of Science ®Google Scholar
• Thomas, M.L. and Brown, E.J. (1999) "Positive and negative regulation of Src-family membrane kinases by CD45", Immunology Today, 20(9), 406–411.
   PubMedGoogle Scholar
• Trowbridge, I.S. (1991) "CD45. A prototype for transmembrane protein tyrosine phosphatases", Journal of Biological Chemistry, 266(35), 23517— 23520.
   Google Scholar
• Bleesing, J.J. and Fleisher, T.A. (2003) "Human B cells express a CD45 isoform that is similar to murine B220 and is downregulated with acquisition of the memory B-cell marker CD27", Cytometry, 51B(1), 1–8.
   PubMedGoogle Scholar
• Hendrickx, A. and Bossuyt, X. (2001) "Quantification of the leukocyte common antigen (CD45) in mature B-cell malignancies", Cytometry, 46(6), 336–339.
   PubMedGoogle Scholar
• Nakamura, A., Tsurusawa, M., Kato, A., Taga, T., Hatae, Y., Miyake, M., et al. (2001) "Prognostic impact of CD45 antigen expression in high-risk, childhood B-cell precursor acute lymphoblastic leukemia", Leukemia & Lymphoma, 42(3), 393–398.
   PubMed Web of Science ®Google Scholar
• Ishikawa, H., Tsuyama, N., Abroun, S., Liu, S., Li, F.J., Taniguchi, O., et al. (2002) "Requirements of src family kinase activity associated with CD45 for myeloma cell proliferation by interleu-kin-6", Blood, 99(6), 2172–2178.
   PubMed Web of Science ®Google Scholar
• Diaz del Pozo, E., Beverly, P.C. and Timon, M. (2000) "Genomic structure and sequence of the leukocyte common antigen (CD45) from the pufferfish Fugu rubripes and comparison with its mammalian homologue", Immunogenetics, 51(10), 838 — 846.
   Google Scholar
• Nagata, T., Suzuki, T., Ohta, Y., Flajnik, M.F. and Kasahara, M. (2002) "The leukocyte common antigen (CD45) of the Pacific hagfish, Eptatretus stoutii: implications for the primordial function of CD45", Immunogenetics, 54(4), 286— 291.
   Google Scholar
• Ko, S., Jaeger, M.D., Dahlke, M.H., Nakajima, Y. and Schlitt, (2002) "Manipulation of CD45 antigen in transplantation toler-ance", Current Molecular Medicine, 2(3), 249–255.
   PubMedGoogle Scholar
• Dahlke, M.H., Lauth, O.S., Jager, M.D., Roeseler, T., Timrott, K., Jackobs, S., et al. (2002) "In vivo depletion of hemopoietic stem cells in the rat by an anti-CD45 (RT7) antibody", Blood, 99(10), 3566— 3572.
   Google Scholar
• Justement, LB. (1997) "The role of CD45 in signal transduction", Advances in Immunology, 66, 1–65.
   PubMed Web of Science ®Google Scholar
• Virts, E., Barritt, D. and Raschke, W.C. (1998) "Expression of CD45 isoforms lacking exons 7, 8 and 10", Molecular Immunology, 35(3), 167–176.
   PubMed Web of Science ®Google Scholar
• Beverley, P.C. (1992) "Functional analysis of human T cell subsets defined by CD45 isoform expression", Seminars in Immunology, 4(1), 35–41.
   PubMedGoogle Scholar
• Beverley, P.C., Daser, A., Michie, C.A. and Wallace, D.L. (1992) "Functional subsets of T cells defined by isoforms of CD45", Biochemical Society Transactions, 20(1), 184–187.
   PubMed Web of Science ®Google Scholar
• Clement, L.T. (1992) "Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation", Journal of Clinical Immunology, 12(1), 1–10.
   PubMed Web of Science ®Google Scholar
• Suarez, A., Mozo, L. and Gutierrez, C. (2002) "Generation of CD4( + )CD45RA( +) effector T cells by stimulation in the presence of cyclic adenosine 5'-monophosphate-elevating agents", Journal Immunology, 169(3), 1159–1167.
   PubMed Web of Science ®Google Scholar
• Tchilian, E.Z., Wallace, DL., Dawes, R., Imami, N., Burton, C., Gotch, F. (2001) "A point mutation in CD45 may be associated with an increased risk of HIV-1 infection", AIDS, 15(14), 1892 — 1894.
   Google Scholar
• Tchilian, E.Z., Dawes, R., Ramaley, P.A., Whitworth, J.A., Yuldasheva, N., Wells, R.S., et al. (2002) "A CD45 polymorphism associated with abnormal splicing is absent in African populations", Immunogenetics, 3(10–11), 980–983.
   Google Scholar
• Barcellos, L.F., Caillier, S., Dragone, L., Elder, M., Vittinghoff, E., Bucher, P., et al. (2001) "PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S.". Nature Genetics, 29(1), 23— 24.
   Google Scholar
• Jacobsen, M., Schweer, D., Ziegler, A., Gaber, R., Schock, S., Schwinzer, R., et al. (2000) "A point mutation in PTPRC is associated with the development of multiple sclerosis", Nature Genetics, 26(4), 495–499.
   PubMed Web of Science ®Google Scholar
• Irles, C., Symons, A., Michel, F., Bakker, T.R., Van Der Merwe, P.A., et al. (2003) "CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling", Nature Immunology, 4(2), 189 — 197.
   Google Scholar
• Yamada, T., Zhu, D., Saxon, A. and Zhang, K. (2002) "CD45 controls interleukin-4-mediated IgE class switch recombination in human B cells through its function as a Janus kinase phosphatase", Journal of Biological Chemistry, 277(32), 28830— 28835.
   Google Scholar
• Altin, J.G. and Sloan, E.K. (1997) "The role of CD45 and CD45-associated molecules in T cell activation", Immunology and Cell Biology, 75(5), 430–445.
   PubMed Web of Science ®Google Scholar
• Alexander, D.R. (2000) "The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function", Seminars in Immunology, 12(4), 349–359.
   PubMed Web of Science ®Google Scholar
• Ashwell, J.D. and D'Oro, U. (1999) "CD45 and Src-family kinases: and now for something completely different". Immunology Today, 20(9), 412–416.
   PubMedGoogle Scholar
• Penninger, J.M., Wallace, V.A., Kishihara, K. and Mak, T.W. (1993) "The role of p561ck and p59fyn tyrosine kinases and CD45 protein tyrosine phosphatase in T-cell development and clonal selection", Immunological Reviews, 135, 183–214.
   PubMed Web of Science ®Google Scholar
• Zhou, C., Saxon, A. and Zhang, K. (2003) "Human activation-induced cytidine deaminase is induced by IL-4 and negatively regulated by CD45: implication of CD45 as a janus kinase phosphatase in antibody diversification", Journal of Immunology, 170(4), 1887–1893.
   PubMed Web of Science ®Google Scholar
• Fernandis, AZ., Cherla, R.P. and Ganju, R.K. (2003) "Differential regulation of CXCR4-mediated T-cell chemotaxis and MAP kinase activation by the membrane tyrosine phosphatase, CD45", Journal of Biological Chemistry, 278(11), 9536–9543.
   PubMed Web of Science ®Google Scholar
• Sasaki, T., Sasaki-Irie, J. and Penninger, J.M. (2001) "New insights into the transmembrane protein tyrosine phosphatase CD45", International Journal of Biochemistry and Cell Biology, 33(11), 1041 — 1046.
   Google Scholar
• Penninger, J.M., Irie-Sasaki, J., Sasaki, T. and Oliveira-dos-Santos, A.J (2001) "CD45: new jobs for an old acquaintance", Nature Immunology, 2(5), 389–396.
   PubMed Web of Science ®Google Scholar
• Caldwell, C.W., Patterson, W.P., Toalson, B.D. and Yesus, Y.W. (1991) "Surface and cytoplasmic expression of CD45 antigen isoforms in normal and malignant myeloid cell differentiation", American Journal of Clinical Pathology, 95(2), 180— 187.
   Google Scholar
• Gao, H., Henderson, A., Flynn, D.C., Landreth, K.S. and Ericson, S.G. (2000) "Effects of the protein tyrosine phosphatase CD45 on FcgammaRIIa signaling and neutrophil finction", Experimental Hematology, 28(9), 1062— 1070.
   Google Scholar
• Yu, C., Yu, H.S., Sun, K.H., Hsieh, S.C. and Tsai, C.Y. (2002) "Anti-CD45 isoform antibodies enhance phagocytosis and gene expression of IL-8 and TNF-alpha in human neutrophils by differential suppression on protein tyrosine phosphorylation and p561ck tyrosine kinase", Clinical and Experimental Immunology, 129(1), 78— 85.
   Google Scholar
• Xu, Z. and Weiss, A. (2002) "Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms", Nature Immunology, 3(8), 764–771.
   PubMed Web of Science ®Google Scholar
• Majeti, R., Xu, Z., Parslow, T.G., Olson, J.L., Daikh, DI., Killeen, N., et al. (2000) "An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity", Cell, 103(7), 1059–1070.
   PubMed Web of Science ®Google Scholar
• Majeti, R., Bilwes, A.M., Noel, J.P., Hunter, T. and Weiss, A. (1998) "Dimerization-induced inhibition of receptor protein tyr-osine phosphatase function through an inhibitory wedge", Science, 279(5347), 88–91.
   PubMed Web of Science ®Google Scholar
• Kung, C., Pingel, J.T., Heikinheimo, M., Klemola, T., Varkila, K., Yoo, L.I., et al. (2000) "Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease", Nature Medicine, 6(3), 343–345.
   PubMed Web of Science ®Google Scholar
• Virts, E.L., Diago, O. and Raschke, W.C. (2003) "A CD45 minigene restores regulated isoform expression and immune function in CD45-deficient mice: therapeutic implications for human CD45-null severe combined immunodeficiency", Blood, 101(3), 849–855.
   PubMed Web of Science ®Google Scholar
• Alsinet, E., Ingles-Esteve, J., Vilella, R., Lozano, F., Mila, J., Rojo, I., et al. (1990) "Differential effects of anti-CD45 monoclonal antibody on human B cell proliferation: a monoclonal antibody recognizing a neuraminidase-sensitive epitope of the T200 molecule enhances anti-immunoglobulin-induced proliferation", European Journal of Immunology, 20(12), 2801–2804.
   PubMed Web of Science ®Google Scholar
• Winfield, J.B., Mimura, T. and Fernsten, P.D. (1992) "Autoanti-bodies to CD45 in systemic lupus erythematosus", International Journal of Clinical and Laboratory Research, 21(4), 292–295.
   PubMedGoogle Scholar
• Winfield, J.B., Fernsten, P., Czyzyk, J., Wang, E. and Marchalonis, J. (1994) "Antibodies to CD45 and other cell membrane antigens in systemic lupus erythematosus", Springer Seminars in Immunopathol-ogy, 16(2–3), 201–210.
   Google Scholar
• Mamoune, A., Durand, V., Le Goff, P., Pennec, Y.L., Youinou, P. and Le Corre, R. (2000) "Abnormal distribution of CD45 isoforms expressed by CD4 + and CD8 + T cells in rheumatoid arthritis", Histology and Histopathology, 15(2), 587–591.
   PubMed Web of Science ®Google Scholar
• Wulf, G.G., Luo, K.L., Goodell, M.A. and Brenner, M.K. (2003) "Anti-CD45-mediated cytoreduction to facilitate allogeneic stem cell transplantation", Blood, 101(6), 2434–2439.
   PubMed Web of Science ®Google Scholar
• Jager, M.D., Tsui, T., Aselmann, H., Dahlke, M.H., Deiwick, A., Neipp, M., et al. (2001) "Features of tolerance achieved by antigen and a single injection of an anti-CD45 monoclonal antibody in rats", Transplantation Proceedings, 33(1–2), 142.
   PubMedGoogle Scholar
• Ko, S., Nakano, H., Deiwick, A., Dinkel, A., Wonigeit, K. and Schlitt, H.J. (1999) "In vitro and in vivo effects of an anti-CD45 monoclonal antibody in the rat", Transplantation Proceedings, 31(5), 1946 — 1947.
   Web of Science ®Google Scholar
• Sandmaier, B.M., Bethge, WA., Wilbur, D.S., Hamlin, D.K., Santos, E.B., Brechbiel, MM., et al. (2002) "Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmye-loablative allogeneic marrow grafts", Blood, 100(1), 318–326.
   PubMed Web of Science ®Google Scholar
• Ruffner, K.L., Martin, P.J., Hussell, S., Nourigat, C., Fisher, D.R., Bernstein, ID., et al. (2001) "Immunosuppressive effects of (131)1-anti-CD45 antibody in unsensitized and donor antigen-presensitized H2-matched, minor antigen-mismatched murine transplant mod-els", Cancer Research, 61(13), 5126–5131.
   PubMed Web of Science ®Google Scholar
• Matthews, D.C., Martin, P.J., Nourigat, C., Appelbaum, FR., Fisher, D.R. and Bernstein, I.D. (1999) "Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models", Blood, 93(2), 737 — 745.
   Google Scholar
• Goldberg, L.C., Bradley, J.A., Connolly, J., Friend, P.J., Oliveira, D.B., Parrott, N.R., et al. (1995) "Anti-CD45 monoclonal antibody perfusion of human renal allografts prior to transplantation. A safety and immunohistological study. CD45 Study Group", Transplantation, 59(9), 1285–1293.
   PubMed Web of Science ®Google Scholar
• Goldberg, L.C., Cook, H.T., Welsh, K.I., Hall, L., Thick, M.G. and Taube, D. (1993) "Optimizing kidney perfusion with anti-CD45 monoclonal antibody", Transplantation Proceedings, 25(1 Pt 2), 1056— 1057.
   Google Scholar
• Shapiro, M.E. and Liu, M. (1995) "Prolongation of islet allograft survival by anti-CD45 antibody pretreatment", Transplantation Proceedings, 27(1), 613–614.
   PubMed Web of Science ®Google Scholar
• Casey, J.J., Manas, D., Gibbs, P., McPhaden, A., Bolton, EM., Bradley, J.A. (1996) "Perfusion of pig hearts with anti-CD45 monoclonal antibody to label interstitial dendritic cells before xenotransplantation", Transplantation Proceedings, 28(2), 801 — 802.
   Google Scholar
• Basadonna, G.P., Auersvald, L., Khuong, C.O., Zheng, X.X., Kashio, N., Zekzer, D., et al. (1998) "Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy", Proceed-ings of National Academy of Sciences of the United States of America, 95(7), 3821–3826.
   PubMed Web of Science ®Google Scholar
• Krance, R., Rill, D., Khan, S., et al. (2001) "Anti-human CD45 (AHCD45) antibody therapy preceding allogeneic stem cell trans-plantation (alloSCT) in high-risk hematologic malignancies", Blood, 98, 777a.
   Google Scholar
• Matthews, D.C., Appelbaum, FR., Eary, J.F., Hui, T.E., Fisher, D.R., Martin, P.J., et al. (1991) "Radiolabeled anti-CD45 mono-clonal antibodies target lymphohemopoietic tissue in the macaque", Blood, 78, 1864 — 1874.
   Google Scholar
• Matthews, D.C., Appelbaum, F.R., Eary, J.F., Fisher, D.R., Durack, L.D., Hui, T.E., et al. (1999) "Phase I study of (131)1-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome.", Blood, 94(4), 1237–1247.
   PubMed Web of Science ®Google Scholar
• Matthews, D.C., Appelbaum, F.R., Eary, J.F., et al. (1999) "131I-anti-CD45 antibody plus busulfan/cyclophosphamide in matched related transplants for AML in first remission", Blood, 94, 711a.
   Google Scholar
• Pagel, J.M., Hedin, N., Subbiah, K., Meyer, D., Mallet, R., Axworthy, D., et al. (2003) "A comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmu-notherapy of B-cell lymphomas", Blood, 101(6), 2340–2348.
   PubMed Web of Science ®Google Scholar
• Ko, S., Deiwick, A., Jager, M.D., Dinkel, A., Rohde, F., Fischer, R., et al. (1999) "The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat", Nature Medicine, 5(11), 1292–1297.
   PubMed Web of Science ®Google Scholar
• Ko, S., Dahlke, M.H., Lauth, O., Jager, M.D., Deiwick, A., Dinkel, A., et al. (2001) "Bone marrow aplasia induced by passenger leukocytes from heart allografts", Experimental Hematology, 29(3), 339 — 344.
   Google Scholar
• Wonigeit, K. (1979) "Characterization of the RT-ly-1 and RT-ly-2 alloantigenic system by congenic rat strains", Transplantation Proceedings, 11(3), 1631–1635.
   PubMed Web of Science ®Google Scholar